MetGen is a Finnish biotechnology company specializing in industrial enzyme solutions and synthetic biology. They help industries transition from fossil-based materials to sustainable, high-value, bio-based alternatives using their proprietary technology platform.
MetGen Oy is a Finnish biotechnology company founded in 2008 that specializes in industrial enzymes and synthetic biology. The company developed the ENZINE® technology platform, which allows for the rapid creation and industrialization of novel, custom-designed enzymes capable of operating in harsh industrial environments. Their expertise combines genetic engineering, protein science, and process engineering to valorize biomass, particularly lignocellulosic materials. By integrating biology with innovative chemistry, MetGen enables the conversion of industrial side streams—such as lignin—into high-value, bio-based alternatives to traditional oil-based products, including resins, foams, adhesives, and coatings.
The company serves industries such as pulp and paper, biofuels, and advanced biochemical manufacturing, helping partners reduce waste and improve energy efficiency. By focusing on market-driven, open-innovation approaches, MetGen collaborates with global industrial partners, engineering firms, and biorefineries to scale these technologies from lab prototypes to commercial production. Their work helps customers transition to sustainable, renewable material value chains, with solutions like the METNIN™ lignin refining technology providing direct replacements for fossil-based components in various material and chemical applications. Proof of their impact is evidenced by numerous European bioeconomy projects and strategic collaborations aimed at industrializing sustainable, bio-based manufacturing.